State Board of Administration of Florida Retirement System’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,550
Closed -$555K 2220
2024
Q3
$555K Hold
9,550
﹤0.01% 1506
2024
Q2
$436K Buy
9,550
+3,180
+50% +$171K ﹤0.01% 1590
2024
Q1
$272K Sell
6,370
-120
-2% -$7.12K ﹤0.01% 1815
2023
Q4
$258K Hold
6,490
﹤0.01% 1965
2023
Q3
$207K Buy
6,490
+100
+2% +$3.73K ﹤0.01% 2039
2023
Q2
$257K Buy
6,390
+20
+0.3% +$877 ﹤0.01% 1972
2023
Q1
$272K Hold
6,370
﹤0.01% 1888
2022
Q4
$306K Sell
6,370
-1,840
-22% -$86K ﹤0.01% 1851
2022
Q3
$309K Hold
8,210
﹤0.01% 1847
2022
Q2
$227K Buy
8,210
+1,800
+28% +$79K ﹤0.01% 2059
2022
Q1
$349K Hold
6,410
﹤0.01% 1949
2021
Q4
$375K Hold
6,410
﹤0.01% 1958
2021
Q3
$254K Hold
6,410
﹤0.01% 2162
2021
Q2
$272K Buy
6,410
+2,210
+53% +$120K ﹤0.01% 2176
2021
Q1
$259K Hold
4,200
﹤0.01% 2111
2020
Q4
$296K Buy
+4,200
New +$265K ﹤0.01% 2012

Other funds holding KROS

State Board of Administration of Florida Retirement System's KROS Position: Q4 2024 in Review

State Board of Administration of Florida Retirement System sold out of Keros Therapeutics (KROS) in Q4 2024, closing a stake of 9,550 shares — an estimated $555K sold.

State Board of Administration of Florida Retirement System first reported a position in KROS in Q4 2020 and held it in 16 quarters. The position peaked at $555K in Q3 2024. 161 funds tracked by Wall St. Rank hold KROS as of Q4 2024.

  • State Board of Administration of Florida Retirement System reported no remaining Keros Therapeutics position as of Q4 2024 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 9,550 Keros Therapeutics shares in Q4 2024, an estimated $555K.
  • State Board of Administration of Florida Retirement System first reported a position in Keros Therapeutics in Q4 2020 and held it in 16 quarters.
  • State Board of Administration of Florida Retirement System's Keros Therapeutics position peaked at $555K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Keros Therapeutics as of Q4 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q4 2024, filed 10 Feb 2025.